| Dr Jason R Dittrich, MD | |
|
2002 Medical Pkwy, Suite #235, Annapolis, MD 21401-3046 | |
| (410) 266-2770 | |
| (410) 841-6251 |
| Full Name | Dr Jason R Dittrich |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 30 Years |
| Location | 2002 Medical Pkwy, Annapolis, Maryland |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1902897895 | NPI | - | NPPES |
| E488 | Other | MD | AAD AA COUNTY |
| 10690026 | Other | MD | BCBS |
| 545L E502 | Other | MD | AAD SHIPLEYS |
| 8317071 | Other | MD | AETNA PPO |
| 300134259 | Other | MD | RR MEDICARE |
| 434340900 | Medicaid | MD | |
| 2622593 | Other | MD | AETNA HMO/POS |
| G01780A06 | Other | MD | AAD PG COUNTY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0204X | Radiology - Vascular & Interventional Radiology | D0058803 (Maryland) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Anne Arundel Medical Center | Annapolis, MD | Hospital |
| Doctors' Community Hospital | Lanham, MD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Luminis Health Imaging, Inc. | 8729054598 | 25 |
| Brown, Croft, Frazier, Pa | 9537101746 | 24 |
| Luminis Health Imaging, Inc. | 8729054598 | 25 |
| Brown, Croft, Frazier, Pa | 9537101746 | 24 |
News Archive
Royal Philips today announced its collaboration with the University of California, Irvine, to explore how spectral breast imaging can improve breast density measurement, potentially aiding clinicians in more accurately gauging breast cancer risks and monitoring changes over time.
According to researcher Mair Underwood, who will present her work at the Emerging Researchers in Ageing (ERA) 2005 conference in Brisbane this week, the current fixation with trying to postpone ageing is increasing and the current older generation may be the last to age gracefully.
Employing a simple new technique to manipulate the sugars that power many front-line drugs, a team of Wisconsin scientists has enhanced the antic-cancer properties of a digitalis, a drug commonly used to treat heart disease.
A new study released as a preprint on the medRxiv* server throws cold water on this notion, however, by demonstrating that in a set of asymptomatic cases, less than a tenth actually had evidence of SARS-CoV-2 infection. This finding has serious implications for the practices mentioned above, since they may be neither justifiable nor cost-effective as means to break the chain of viral transmission.
An experimental treatment that combines a cell-killing radioactive particle with an antibody that homes in on cancer cells is safe in the treatment of cancers spreading through patients' abdomens, according to data from a first-in-human study presented today at the Society of Nuclear Medicine and Molecular Imaging annual meeting in Vancouver.
› Verified 6 days ago
| Entity Name | Luminis Health Imaging, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194825240 PECOS PAC ID: 8729054598 Enrollment ID: O20041228000266 |
News Archive
Royal Philips today announced its collaboration with the University of California, Irvine, to explore how spectral breast imaging can improve breast density measurement, potentially aiding clinicians in more accurately gauging breast cancer risks and monitoring changes over time.
According to researcher Mair Underwood, who will present her work at the Emerging Researchers in Ageing (ERA) 2005 conference in Brisbane this week, the current fixation with trying to postpone ageing is increasing and the current older generation may be the last to age gracefully.
Employing a simple new technique to manipulate the sugars that power many front-line drugs, a team of Wisconsin scientists has enhanced the antic-cancer properties of a digitalis, a drug commonly used to treat heart disease.
A new study released as a preprint on the medRxiv* server throws cold water on this notion, however, by demonstrating that in a set of asymptomatic cases, less than a tenth actually had evidence of SARS-CoV-2 infection. This finding has serious implications for the practices mentioned above, since they may be neither justifiable nor cost-effective as means to break the chain of viral transmission.
An experimental treatment that combines a cell-killing radioactive particle with an antibody that homes in on cancer cells is safe in the treatment of cancers spreading through patients' abdomens, according to data from a first-in-human study presented today at the Society of Nuclear Medicine and Molecular Imaging annual meeting in Vancouver.
› Verified 6 days ago
| Entity Name | Brown, Croft, Frazier, Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902807324 PECOS PAC ID: 9537101746 Enrollment ID: O20240111000011 |
News Archive
Royal Philips today announced its collaboration with the University of California, Irvine, to explore how spectral breast imaging can improve breast density measurement, potentially aiding clinicians in more accurately gauging breast cancer risks and monitoring changes over time.
According to researcher Mair Underwood, who will present her work at the Emerging Researchers in Ageing (ERA) 2005 conference in Brisbane this week, the current fixation with trying to postpone ageing is increasing and the current older generation may be the last to age gracefully.
Employing a simple new technique to manipulate the sugars that power many front-line drugs, a team of Wisconsin scientists has enhanced the antic-cancer properties of a digitalis, a drug commonly used to treat heart disease.
A new study released as a preprint on the medRxiv* server throws cold water on this notion, however, by demonstrating that in a set of asymptomatic cases, less than a tenth actually had evidence of SARS-CoV-2 infection. This finding has serious implications for the practices mentioned above, since they may be neither justifiable nor cost-effective as means to break the chain of viral transmission.
An experimental treatment that combines a cell-killing radioactive particle with an antibody that homes in on cancer cells is safe in the treatment of cancers spreading through patients' abdomens, according to data from a first-in-human study presented today at the Society of Nuclear Medicine and Molecular Imaging annual meeting in Vancouver.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jason R Dittrich, MD 2002 Medical Pkwy, Suite #235, Annapolis, MD 21401-3046 Ph: (410) 266-2770 | Dr Jason R Dittrich, MD 2002 Medical Pkwy, Suite #235, Annapolis, MD 21401-3046 Ph: (410) 266-2770 |
News Archive
Royal Philips today announced its collaboration with the University of California, Irvine, to explore how spectral breast imaging can improve breast density measurement, potentially aiding clinicians in more accurately gauging breast cancer risks and monitoring changes over time.
According to researcher Mair Underwood, who will present her work at the Emerging Researchers in Ageing (ERA) 2005 conference in Brisbane this week, the current fixation with trying to postpone ageing is increasing and the current older generation may be the last to age gracefully.
Employing a simple new technique to manipulate the sugars that power many front-line drugs, a team of Wisconsin scientists has enhanced the antic-cancer properties of a digitalis, a drug commonly used to treat heart disease.
A new study released as a preprint on the medRxiv* server throws cold water on this notion, however, by demonstrating that in a set of asymptomatic cases, less than a tenth actually had evidence of SARS-CoV-2 infection. This finding has serious implications for the practices mentioned above, since they may be neither justifiable nor cost-effective as means to break the chain of viral transmission.
An experimental treatment that combines a cell-killing radioactive particle with an antibody that homes in on cancer cells is safe in the treatment of cancers spreading through patients' abdomens, according to data from a first-in-human study presented today at the Society of Nuclear Medicine and Molecular Imaging annual meeting in Vancouver.
› Verified 6 days ago
Luqman K Dad, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 2002 Medical Pkwy, Suite 235, Annapolis, MD 21401 Phone: 410-266-2770 Fax: 410-841-6251 | |
Dr. Quang Nguyen, Radiology Medicare: Accepting Medicare Assignments Practice Location: 2001 Medical Pkwy, Annapolis, MD 21401 Phone: 410-266-2770 Fax: 410-841-6251 | |
Dr. Mark S Radowich, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 2002 Medical Pkwy, Suite 235, Annapolis, MD 21401 Phone: 410-266-2770 Fax: 410-841-6251 | |
Dr. Thomas B. Lank, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 122 Defense Hwy, Chesapeake Medical Imaging, Annapolis, MD 21401 Phone: 410-571-0350 Fax: 410-571-9348 | |
Dr. Frank J Groshek, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 2002 Medical Pkwy Ste 235, Annapolis, MD 21401 Phone: 410-266-2770 Fax: 410-841-6251 | |
Dr. Mark Cameron Davis, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 845 Coachway, Annapolis, MD 21401 Phone: 952-595-1100 Fax: 612-294-4903 | |
Dr. Kerry J. Thompson, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 2002 Medical Pkwy, Suite #235, Annapolis, MD 21401 Phone: 410-266-2770 Fax: 410-841-6251 |